Notice of Intent to Sole Source – BD BIOSCIENCES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves a five-year service agreement with BD BIOSCIENCES for maintenance and support of specific flow cytometry equipment, including two sets of BD FACSLyric flow cytometers with Universal Loaders and two sets of BD Lyse/Wash Assistants. These devices are integral to processing patient samples such as licensed blood products and cellular therapy products for clinical research, cell therapeutic development, gene modification testing, and quality control of cell selection methods. BD BIOSCIENCES is recognized as the sole provider capable of delivering the necessary periodic preventive maintenance for these instruments. The procurement follows Federal Acquisition Regulation Part 13 - Simplified Acquisition Procedures and allows a sole-source purchase due to the unique availability of the vendor, exempting it from competitive bidding requirements under FAR Part 6. The NIH Clinical Center Office of Purchasing and Contracts is managing the contract, with a designated point of contact for comments before the closing date. This notice clarifies that it is an intent to procure and not a request for quotations or solicitations. The contract is managed under solicitation number NOI-OD-26-003977 and will be executed in Bethesda, Maryland.
General Info
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Organization & Contact Information
Full Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for a five year service contract with BD BIOSCIENCES for two sets of BD FACSLyric flow cytometers (S/N: Z662383000114, Z662383000115) with Universal Loaders (S/N: Z662462000213, Z662462000214) as well as two sets of BD Lyse/Wash Assistants (LWAs) (S/N: RR337146001216, RR337146001208). These instruments are used to process patient samples including both licensed blood products and cellular therapy products, and to identify cell population from blood and cell products for clinical research and cell therapeutic product development. It can also provide guidance in test of our gene modification efficiencies, and QC our cell selection methods. BD Biosciences is the sole vendor to provide the periodic Preventive Maintenance (PM) for the mentioned devices.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to contact@example.gov by close date.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
